MTNB Hisse Senedi Fiyat Grafiği
MTNB Kazanmak
Matinas BioPharma Holdings Inc
$0.7
5.1%
$0.03
Kapanışta: May 22, 16:00:00 GMT-4
$0.65
-6.76%
$-0.04
Sonrası Piyasa: May 22, 20:00:00 GMT-4
Geri
Matinas BioPharma Holdings Inc (MTNB) Kazanmak
Önemli İstatistikler
Önceki Kapanış
$0.6699
Açılış fiyatı
$0.6498
Günün Aralığı
$0.63 - $0.7065
52 haftalık aralık
$0.48 - $3.09
İşlem hacmi
42.4K
Ort.Hacim
29.8K
Dividend yield
--
EPS (TTM)
-1.62
Piyasa Değeri
$4.2M
MTNB nedir?
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Bedminster, New Jersey and currently employs 2 full-time employees. The company went IPO on 2014-06-03. The firm is focused on delivering therapies using its lipid nanocrystal (LNC) platform delivery technology. Its lead product candidate is MAT2203 (oral amphotericin B), a highly potent antifungal drug which, by virtue of LNC delivery, has been made oral, safe, and well-tolerated for prolonged administration in patients with life-threatening invasive fungal infections. MAT2203 has completed a Phase II encochleated oral amphotericin for cryptococcal meningitis trial (EnACT) study in HIV patients suffering from cryptococcal meningitis, meeting its primary endpoint and achieving robust survival. MAT2203 is now positioned for a single, Phase III registration trial (the ORALTO trial) in support of a New Drug Application (NDA) for the treatment of invasive aspergillosis in patients with limited treatment options.
